Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: June 13, 2023
The
relentless
evolution
of
SARS-CoV-2
poses
a
significant
threat
to
public
health,
as
it
adapts
immune
pressure
from
vaccines
and
natural
infections.
Gaining
insights
into
potential
antigenic
changes
is
critical
but
challenging
due
the
vast
sequence
space.
Here,
we
introduce
Machine
Learning-guided
Antigenic
Evolution
Prediction
(MLAEP),
which
combines
structure
modeling,
multi-task
learning,
genetic
algorithms
predict
viral
fitness
landscape
explore
via
in
silico
directed
evolution.
By
analyzing
existing
variants,
MLAEP
accurately
infers
variant
order
along
evolutionary
trajectories,
correlating
with
corresponding
sampling
time.
Our
approach
identified
novel
mutations
immunocompromised
COVID-19
patients
emerging
variants
like
XBB1.5.
Additionally,
predictions
were
validated
through
vitro
neutralizing
antibody
binding
assays,
demonstrating
that
predicted
exhibited
enhanced
evasion.
profiling
predicting
changes,
aids
vaccine
development
enhances
preparedness
against
future
variants.
The EMBO Journal,
Journal Year:
2024,
Volume and Issue:
43(8), P. 1484 - 1498
Published: March 11, 2024
Abstract
Since
SARS-CoV-2
Omicron
variant
emerged,
it
is
constantly
evolving
into
multiple
sub-variants,
including
BF.7,
BQ.1,
BQ.1.1,
XBB,
XBB.1.5
and
the
recently
emerged
BA.2.86
JN.1.
Receptor
binding
immune
evasion
are
recognized
as
two
major
drivers
for
evolution
of
receptor
domain
(RBD)
spike
(S)
protein.
However,
underlying
mechanism
interplay
between
factors
remains
incompletely
understood.
Herein,
we
determined
structures
human
ACE2
complexed
with
XBB
RBDs.
Based
on
ACE2/RBD
these
sub-variants
a
comparison
known
complex
structures,
found
that
R346T
substitution
in
RBD
enhanced
upon
an
interaction
residue
R493,
but
not
Q493,
via
involving
long-range
conformation
changes.
Furthermore,
R493Q
F486V
exert
balanced
impact,
through
which
capability
was
somewhat
compromised
to
achieve
optimal
binding.
We
propose
“two-steps-forward
one-step-backward”
model
describe
such
compromise
affinity
during
sub-variants.
PLoS Biology,
Journal Year:
2024,
Volume and Issue:
22(11), P. e3002916 - e3002916
Published: Nov. 12, 2024
H5
influenza
is
considered
a
potential
pandemic
threat.
Recently,
viruses
belonging
to
clade
2.3.4.4b
have
caused
large
outbreaks
in
avian
and
multiple
nonhuman
mammalian
species.
Previous
studies
identified
molecular
phenotypes
of
the
viral
hemagglutinin
(HA)
protein
that
contribute
humans,
including
cell
entry,
receptor
preference,
HA
stability,
reduced
neutralization
by
polyclonal
sera.
However,
prior
experimental
work
has
only
measured
how
these
are
affected
handful
>10,000
different
possible
amino-acid
mutations
HA.
Here,
we
use
pseudovirus
deep
mutational
scanning
measure
all
affect
each
phenotype.
We
identify
allow
better
bind
α2-6-linked
sialic
acids
show
some
already
carry
stabilize
also
sera
from
mice
ferrets
vaccinated
against
or
infected
with
viruses.
These
antigenic
maps
enable
rapid
assessment
when
new
strains
acquired
may
create
mismatches
candidate
vaccine
virus,
mutation
present
recent
HAs
causes
change.
Overall,
systematic
nature
combined
safety
pseudoviruses
enables
comprehensive
measurements
phenotypic
effects
can
inform
real-time
interpretation
variation
observed
during
surveillance
influenza.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 22, 2024
Abstract
The
continuous
evolution
of
SARS-CoV-2,
particularly
the
emergence
BA.2.86/JN.1
lineage
replacing
XBB
lineages,
necessitates
re-evaluation
current
vaccine
compositions.
Here,
we
provide
a
comprehensive
analysis
humoral
immune
response
to
and
JN.1
human
exposures,
emphasizing
need
for
JN.1-lineage-based
boosters.
We
demonstrate
antigenic
distinctiveness
lineages
in
SARS-CoV-2-naive
individuals
but
not
those
with
prior
vaccinations
or
infections,
infection
elicits
superior
plasma
neutralization
titers
against
its
subvariants.
highlight
strong
evasion
receptor
binding
capability
KP.3,
supporting
foreseeable
prevalence.
Extensive
BCR
repertoire,
isolating
∼2000
RBD-specific
monoclonal
antibodies
(mAbs)
their
targeting
epitopes
characterized
by
deep
mutational
scanning
(DMS),
underscores
systematic
superiority
JN.1-elicited
memory
B
cells
(MBCs).
Notably,
Class
1
IGHV3-53/3-66-derived
neutralizing
(NAbs)
contribute
majorly
within
wildtype
(WT)-reactive
NAbs
JN.1.
However,
KP.2
KP.3
evade
substantial
subset
them,
even
induced
JN.1,
advocating
booster
updates
optimized
enrichment.
JN.1-induced
Omicron-specific
also
high
potency
across
all
Omicron
lineages.
Escape
hotspots
these
have
mainly
been
mutated
RBD,
resulting
higher
barrier
escape,
considering
probable
recovery
previously
escaped
NAbs.
Additionally,
prevalence
broadly
reactive
IGHV3-53/3-66-
encoding
MBCs,
competing
suggests
inhibitory
role
on
de
novo
activation
naive
cells,
potentially
explaining
heavy
imprinting
mRNA-vaccinated
individuals.
These
findings
delineate
evolving
antibody
shift
from
importance
developing
lineage,
especially
KP.3-based
boosters,
enhance
immunity
future
SARS-CoV-2
variants.
Nature Communications,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: June 13, 2023
The
relentless
evolution
of
SARS-CoV-2
poses
a
significant
threat
to
public
health,
as
it
adapts
immune
pressure
from
vaccines
and
natural
infections.
Gaining
insights
into
potential
antigenic
changes
is
critical
but
challenging
due
the
vast
sequence
space.
Here,
we
introduce
Machine
Learning-guided
Antigenic
Evolution
Prediction
(MLAEP),
which
combines
structure
modeling,
multi-task
learning,
genetic
algorithms
predict
viral
fitness
landscape
explore
via
in
silico
directed
evolution.
By
analyzing
existing
variants,
MLAEP
accurately
infers
variant
order
along
evolutionary
trajectories,
correlating
with
corresponding
sampling
time.
Our
approach
identified
novel
mutations
immunocompromised
COVID-19
patients
emerging
variants
like
XBB1.5.
Additionally,
predictions
were
validated
through
vitro
neutralizing
antibody
binding
assays,
demonstrating
that
predicted
exhibited
enhanced
evasion.
profiling
predicting
changes,
aids
vaccine
development
enhances
preparedness
against
future
variants.